Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice
Background: Nowadays, metabolic syndromes represent one of the major public health challenges worldwide and are twice as prevalent in patients with neuropsychiatric disorders. This could be due to antipsychotic consumption, especially atypical ones, such as olanzapine (OLA), a second-generation anti...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mazandaran University of Medical Sciences
2024-10-01
|
| Series: | Pharmaceutical and Biomedical Research |
| Subjects: | |
| Online Access: | http://pbr.mazums.ac.ir/article-1-629-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041837101776896 |
|---|---|
| author | Khadiza Begum Md Abdur Rahman Ripon Tabassum Akter Md Monirul Islam Rahima Begum Mohammad Salim Hossain |
| author_facet | Khadiza Begum Md Abdur Rahman Ripon Tabassum Akter Md Monirul Islam Rahima Begum Mohammad Salim Hossain |
| author_sort | Khadiza Begum |
| collection | DOAJ |
| description | Background: Nowadays, metabolic syndromes represent one of the major public health challenges worldwide and are twice as prevalent in patients with neuropsychiatric disorders. This could be due to antipsychotic consumption, especially atypical ones, such as olanzapine (OLA), a second-generation antipsychotic used in the management of schizophrenia.
Objectives: This study explores the potential of chronic OLA exposure to modulate inflammatory pathways in a context of metabolic dysfunction using high-fat diet (HFD) induced obese mice (female).
Methods: A total of 1 mg/kg of OLA and HFD were given for 6 weeks to an obese mice group as treatment. Then, body weight, abdominal fat weight, lipid profiles (serum triglycerides (TG), total cholesterol (TC), and high-density lipoprotein cholesterol [HDL-C]), and liver functions (serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase, and alkaline phosphatase [ALP]) were assessed against the HFD control group. The relative gene expression of PPAR-ɣ, MCP-1, and GLUT4 were also compared.
Results: This treatment of OLA (1 mg/kg) induced a significant decrease in TG, SGOT, and serum glutamic-pyruvic transaminase levels, and a non-significant decrease in body weight, abdominal fat mass, TC, HDL-C, ALP level and the expression of MCP-1 and PPAR-γ; however, GLUT4 was significantly increased.
Conclusion: After chronic OLA exposure, the results indicate that the declination of body and organ weight, lipid levels, liver function markers, and MCP-1 and PPAR-ɣ expression except for GLUT4 shows its effects in changing the metabolic disturbances in obese mice. |
| format | Article |
| id | doaj-art-bd56782c99c84ca2ade406b45e915e0c |
| institution | DOAJ |
| issn | 2423-4494 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Mazandaran University of Medical Sciences |
| record_format | Article |
| series | Pharmaceutical and Biomedical Research |
| spelling | doaj-art-bd56782c99c84ca2ade406b45e915e0c2025-08-20T02:55:41ZengMazandaran University of Medical SciencesPharmaceutical and Biomedical Research2423-44942024-10-01104345354Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese MiceKhadiza Begum0Md Abdur Rahman Ripon1Tabassum Akter2Md Monirul Islam3Rahima Begum4Mohammad Salim Hossain5 Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Background: Nowadays, metabolic syndromes represent one of the major public health challenges worldwide and are twice as prevalent in patients with neuropsychiatric disorders. This could be due to antipsychotic consumption, especially atypical ones, such as olanzapine (OLA), a second-generation antipsychotic used in the management of schizophrenia. Objectives: This study explores the potential of chronic OLA exposure to modulate inflammatory pathways in a context of metabolic dysfunction using high-fat diet (HFD) induced obese mice (female). Methods: A total of 1 mg/kg of OLA and HFD were given for 6 weeks to an obese mice group as treatment. Then, body weight, abdominal fat weight, lipid profiles (serum triglycerides (TG), total cholesterol (TC), and high-density lipoprotein cholesterol [HDL-C]), and liver functions (serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase, and alkaline phosphatase [ALP]) were assessed against the HFD control group. The relative gene expression of PPAR-ɣ, MCP-1, and GLUT4 were also compared. Results: This treatment of OLA (1 mg/kg) induced a significant decrease in TG, SGOT, and serum glutamic-pyruvic transaminase levels, and a non-significant decrease in body weight, abdominal fat mass, TC, HDL-C, ALP level and the expression of MCP-1 and PPAR-γ; however, GLUT4 was significantly increased. Conclusion: After chronic OLA exposure, the results indicate that the declination of body and organ weight, lipid levels, liver function markers, and MCP-1 and PPAR-ɣ expression except for GLUT4 shows its effects in changing the metabolic disturbances in obese mice.http://pbr.mazums.ac.ir/article-1-629-en.pdfhigh-fat diet (hfd)metabolic syndromeobesityolanzapine (ola)gene expression |
| spellingShingle | Khadiza Begum Md Abdur Rahman Ripon Tabassum Akter Md Monirul Islam Rahima Begum Mohammad Salim Hossain Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice Pharmaceutical and Biomedical Research high-fat diet (hfd) metabolic syndrome obesity olanzapine (ola) gene expression |
| title | Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice |
| title_full | Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice |
| title_fullStr | Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice |
| title_full_unstemmed | Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice |
| title_short | Investigating the Effects of Olanzapine in Changes in Metabolic Syndrome in High-fat diet-induced Obese Mice |
| title_sort | investigating the effects of olanzapine in changes in metabolic syndrome in high fat diet induced obese mice |
| topic | high-fat diet (hfd) metabolic syndrome obesity olanzapine (ola) gene expression |
| url | http://pbr.mazums.ac.ir/article-1-629-en.pdf |
| work_keys_str_mv | AT khadizabegum investigatingtheeffectsofolanzapineinchangesinmetabolicsyndromeinhighfatdietinducedobesemice AT mdabdurrahmanripon investigatingtheeffectsofolanzapineinchangesinmetabolicsyndromeinhighfatdietinducedobesemice AT tabassumakter investigatingtheeffectsofolanzapineinchangesinmetabolicsyndromeinhighfatdietinducedobesemice AT mdmonirulislam investigatingtheeffectsofolanzapineinchangesinmetabolicsyndromeinhighfatdietinducedobesemice AT rahimabegum investigatingtheeffectsofolanzapineinchangesinmetabolicsyndromeinhighfatdietinducedobesemice AT mohammadsalimhossain investigatingtheeffectsofolanzapineinchangesinmetabolicsyndromeinhighfatdietinducedobesemice |